04 Nov 2022
Significant weight loss has been reported from the phase 3 trial of once-weekly injection of semaglutide in 12 to 18 year olds with obesity. The positive findings have been published in the New England Journal of Medicine.
Research Assistant in Endocrinology (University of Sheffield)
14 May 2024
BSPED Research and Innovation Award 2024 now open
03 May 2024
Nurse and Allied Health Professionals Award 2024 – applications now open
03 May 2024
Committee opportunity: Clinical Standards Officer
03 May 2024
Updated: UK Paediatric Endocrine Standards
03 May 2024